Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
+123K
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
+$9.46M
-
Put/Call ratio
-
1.8
-
Number of buys
-
74
-
Number of sells
-
-64
-
Price
-
$80.06
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2023
183 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q1 2023.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 29.1M outstanding shares and own 72.15% of the company stock.
Largest 10 shareholders include FMR LLC (2.2M shares), Redmile Group, LLC (1.91M shares), Avoro Capital Advisors LLC (1.75M shares), BlackRock Inc. (1.72M shares), VANGUARD GROUP INC (1.2M shares), STATE STREET CORP (1.03M shares), LORD, ABBETT & CO. LLC (961K shares), Frazier Life Sciences Management, L.P. (945K shares), CREDIT SUISSE AG/ (633K shares), and PICTET ASSET MANAGEMENT SA (632K shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.